Jiale Zhang
Beijing, 100700, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
ZhiXiaoSanZheng formula ameliorates podocyte injury in diabetic kidney disease by inhibiting ferroptosis: integrated network pharmacology and experimental validation.
Journal: Chinese medicine
Published: January 24, 2026
Pholidota chinensis Lindl alleviates diabetic kidney disease by restoring mitochondrial dynamics and promoting mitophagy.
Journal: Journal of ethnopharmacology
Published: January 18, 2026
Mechanistic study on HuaganJiedu decoction in treating hepatitis B based on multi-omics analysis of network pharmacology, metabolomics, and transcriptomics.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 20, 2025
Qing-Re-Xiao-Zheng-(Yi-Qi) formula attenuates the renal podocyte ferroptosis in diabetic kidney disease through AMPK pathway.
Journal: Journal of ethnopharmacology
Published: February 21, 2025
Surrogate endpoints in diabetic kidney disease: current perspectives and future directions.
Journal: Frontiers in endocrinology
Published: February 06, 2025
ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity.
Journal: Drug design, development and therapy
Published: December 30, 2024
Kaempferol improves mitochondrial homeostasis via mitochondrial dynamics and mitophagy in diabetic kidney disease.
Journal: International immunopharmacology
Published: December 18, 2024
The combined impact of BMI and ABSI on all-cause mortality among American adults with diabetes.
Journal: Diabetology & metabolic syndrome
Published: December 06, 2024
Antiviral activity of HuaganJiedu decoction (HGJDD) against hepatitis B virus (HBV) through FOXO4/ERK/HNF4α signal pathway.
Journal: Journal of ethnopharmacology
Published: September 26, 2024
Association between visceral adiposity index and incidence of diabetic kidney disease in adults with diabetes in the United States.
Journal: Scientific reports
Published: April 03, 2024
Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
Journal: Frontiers in endocrinology
Published: January 10, 2024
Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease.
Journal: Frontiers in endocrinology
Published: November 07, 2023
Last Updated: 09/26/2026